SPT-07A injection
Phase 3UNKNOWN 1 views this week 0 watching💤 Quiet
Interest: 36/100
36
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Stroke, Acute
Conditions
Stroke, Acute
Trial Timeline
Jan 20, 2022 → Jan 10, 2024
NCT ID
NCT05159947About SPT-07A injection
SPT-07A injection is a phase 3 stage product being developed by Sinopharm for Stroke, Acute. The current trial status is unknown. This product is registered under clinical trial identifier NCT05159947. Target conditions include Stroke, Acute.
What happened to similar drugs?
7 of 20 similar drugs in Stroke, Acute were approved
Approved (7) Terminated (6) Active (9)
Hype Score Breakdown
Clinical
17
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05159947 | Phase 3 | UNKNOWN |
Competing Products
20 competing products in Stroke, Acute